Clinical Trial Update: Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of AT-5214 for palmar hyperhidrosis is ongoing, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis
• Palmar Hyperhidrosis

Drugs mentioned

• AT-5214

Snippet

Sponsor: Atacama Therapeutics | Conditions: Hyperhidrosis, Palmar Hyperhidrosis | Phase 2 | Status: UNKNOWN